Lexeo Therapeutics Inc Annual Shareholders Meeting Transcript
Good morning, and welcome to Lexeo Therapeutics' 2026 Annual Meeting of Stockholders. I am Nolan Townsend, CEO of Lexeo Therapeutics and a member of its Board of Directors. I will preside as Chair of this meeting, which I now call to order.
With us today are members from management, including Louis Tamayo, our Chief Financial Officer and Corporate Secretary; Youjin Choi, our Vice President, Assistant General Counsel; and Ryan McHenry, Vice President, Corporate Controller.
Also with us are members of our Board of Directors; and Harry Cohen of KPMG LLP, our independent public accountants; Megan Baer of Wilson Sonsini Goodrich & Rosati, our outside corporate counsel.
Katherine Wheadon of the Carideo Group, who has been appointed Inspector of Election for this meeting and assigned oath of office, which will be filed with the minutes of this meeting.
And now, I would like to turn the formal portion of the meeting over to Louis Tamayo, our Chief Financial Officer. Louis will act as Secretary
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
